Skip to main content
. 2023 Dec 1;13(1):177. doi: 10.1038/s41408-023-00951-2

Table 1.

Characteristics of BM aspirated samples.

Characteristic All samples (n = 351) MGUS (n = 128) SMM (n = 186) MM (n = 37)
age, median (range) 69 (43–89) 69 (43–88) 68 (44–88) 70 (49–89)
sex (%) 63% M - 37% F 43% M - 57% F 64% M - 36% F 78% M - 22% F
Type, no. (%)
 IgG 167 (47.6%) 68 (53.1%) 81 (43.5%) 18 (48.6%)
 IgA 94 (26.8%) 30 (23.4%) 58 (31.2%) 6 (16.2%)
 biclonal 30 (8.5%) 12 (9.4%) 15 (8.1%) 3 (8.1%)
 light-chaina 60 (17.1%) 18 (14.1%) 32 (17.2%) 10 (27.0%)
M-proteinb (g/dL), median (IQR) 5.0 (1.0-11.0) 1.0 (0.2-3.0) 7.3 (4.0-13.0) 16.2 (8.0-53.0)
FLC ratioc, median (IQR) 15.6 (5.3-53.1) 3.2 (2.1-4.6) 19.1 (12.0-41.3) 183 (131-321)
BMPCd (%), median (IQR) 13% (8%-26%) 8% (3%-8%) 18% (16%-26%) 51% (33%-66%)
BM sample pull, no (%)
 first 219 (62.4%) 44 (34.4%) 143 (76.9%) 32 (86.5%)
 second 132 (37.6%) 84 (65.6%) 43 (23.1%) 5 (13.5%)

MGUS monoclonal gammopathy of undetermined significance, SMM smoldering multiple myeloma, MM multiple myeloma, Ig immunoglobulin, BM bone marrow, M monoclonal, FLC free light-chain, BMPC bone marrow plasma cells, IQR Interquartile range. aLight-chain monoclonal gammopathy (abnormal light-chain levels and no detected M-protein); btotal serum M-protein concentration for individuals with identified M-protein; cFLC ratio (involved/uninvolved) for individuals with light-chain monoclonal gammopathy; dBMPC count by aspirate and biopsy with the higher value used (available for 336/351 samples).